Bladder cancer
L Dyrskjøt, DE Hansel, JA Efstathiou… - Nature Reviews …, 2023 - nature.com
Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …
Managing metastatic melanoma in 2022: a clinical review
B Switzer, I Puzanov, JJ Skitzki, L Hamad… - JCO oncology …, 2022 - ascopubs.org
Cutaneous melanoma remains the most lethal of the primary cutaneous neoplasms, and
although the incidence of primary melanoma continues to rise, the mortality from metastatic …
although the incidence of primary melanoma continues to rise, the mortality from metastatic …
Treatment of metastatic colorectal cancer: ASCO guideline
PURPOSE To develop recommendations for treatment of patients with metastatic colorectal
cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic …
cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic …
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
LE Hendriks, KM Kerr, J Menis, TS Mok… - Annals of …, 2023 - annalsofoncology.org
Diagnosis of tumour type allows prognostication and triage for biomarker testing (see the
Supplementary Material Section 3 and Supplementary Figure S1, available at https://doi …
Supplementary Material Section 3 and Supplementary Figure S1, available at https://doi …
Management of salivary gland malignancy: ASCO guideline
JL Geiger, N Ismaila, B Beadle, JJ Caudell… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …
other healthcare providers on the management of salivary gland malignancy. METHODS …
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
XS Wang, YF Bai, V Verma, RL Yu… - JNCI: Journal of the …, 2023 - academic.oup.com
Background Adding radiotherapy (RT) to systemic therapy improves progression-free
survival (PFS) and overall survival (OS) in oligometastatic non-small cell lung cancer …
survival (PFS) and overall survival (OS) in oligometastatic non-small cell lung cancer …
Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes
Purpose Long-term randomized data assessing the effect of ablative therapies in patients
with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the …
with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the …
Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis
Importance The oligometastatic paradigm postulates that patients with a limited number of
metastases can be treated with ablative local therapy to each site of disease with curative …
metastases can be treated with ablative local therapy to each site of disease with curative …
Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine: phase 3 results of NRG Oncology/RTOG 0631 randomized …
S Ryu, S Deshmukh, RD Timmerman, B Movsas… - JAMA …, 2023 - jamanetwork.com
Importance Spine metastasis can be treated with high-dose radiation therapy with advanced
delivery technology for long-term tumor and pain control. Objective To assess whether …
delivery technology for long-term tumor and pain control. Objective To assess whether …
Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer: the EXTEND phase 2 randomized clinical trial
Importance Despite evidence demonstrating an overall survival benefit with up-front
hormone therapy in addition to established synergy between hormone therapy and …
hormone therapy in addition to established synergy between hormone therapy and …